CCM
MLAB icon

Coldstream Capital Management’s Mesa Laboratories MLAB Stock Holding History

Coldstream Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-57
Closed -$6.76K – 2430
2025
Q1 		$6.76K Buy
+57
New +$7.77K ﹤0.01% 2551

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM

Coldstream Capital Management's MLAB Position: Q2 2025 in Review

Coldstream Capital Management sold out of Mesa Laboratories (MLAB) in Q2 2025, closing a stake of 57 shares — an estimated $6.76K sold.

Coldstream Capital Management first reported a position in MLAB in Q1 2025 and held it in 1 quarter. The position peaked at $6.76K in Q1 2025. 154 funds tracked by Wall St. Rank hold MLAB as of Q2 2025.

  • Coldstream Capital Management reported no remaining Mesa Laboratories position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 57 Mesa Laboratories shares in Q2 2025, an estimated $6.76K.
  • Coldstream Capital Management first reported a position in Mesa Laboratories in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Mesa Laboratories position peaked at $6.76K in Q1 2025.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.